Interaction of eukaryotic translation initiation factor 4G with the nuclear cap-binding complex provides a link between nuclear and cytoplasmic functions of the m7 guanosine cap by McKendrick, Linda et al.
  
10.1128/MCB.21.11.3632-3641.2001. 
2001, 21(11):3632. DOI:Mol. Cell. Biol. 
Simon J. Morley and Joe D. Lewis
Linda McKendrick, Elizabeth Thompson, Joao Ferreira,
 
Guanosine Cap7Functions of the m
between Nuclear and Cytoplasmic 
Cap-Binding Complex Provides a Link
Initiation Factor 4G with the Nuclear 
Interaction of Eukaryotic Translation
http://mcb.asm.org/content/21/11/3632
Updated information and services can be found at: 
These include:
REFERENCES
http://mcb.asm.org/content/21/11/3632#ref-list-1at: 
This article cites 57 articles, 34 of which can be accessed free
CONTENT ALERTS
 more»articles cite this article), 
Receive: RSS Feeds, eTOCs, free email alerts (when new
http://journals.asm.org/site/misc/reprints.xhtmlInformation about commercial reprint orders: 
http://journals.asm.org/site/subscriptions/To subscribe to to another ASM Journal go to: 
 o
n
 June 19, 2014 by guest
http://m
cb.asm
.org/
D
ow
nloaded from
 
 o
n
 June 19, 2014 by guest
http://m
cb.asm
.org/
D
ow
nloaded from
 
MOLECULAR AND CELLULAR BIOLOGY,
0270-7306/01/$04.0010 DOI: 10.1128/MCB.21.11.3632–3641.2001
June 2001, p. 3632–3641 Vol. 21, No. 11
Copyright © 2001, American Society for Microbiology. All Rights Reserved.
Interaction of Eukaryotic Translation Initiation Factor 4G
with the Nuclear Cap-Binding Complex Provides a Link
between Nuclear and Cytoplasmic Functions
of the m7 Guanosine Cap
LINDA MCKENDRICK,1 ELIZABETH THOMPSON,2 JOAO FERREIRA,3
SIMON J. MORLEY,1 AND JOE D. LEWIS2*
Department of Biochemistry, School of Biological Sciences, University of Sussex, Falmer, Brighton BN1 9QG,1 and Wellcome
Trust Centre for Cell Biology, University of Edinburgh, Edinburgh EH9 3JR,2 United Kingdom, and Institute of Histology,
Faculty of Medicine, 1649-028 Lisbon, Portugal3
Received 27 December 2000/Returned for modification 18 January 2001/Accepted 6 March 2001
In eukaryotes the majority of mRNAs have an m7G cap that is added cotranscriptionally and that plays an
important role in many aspects of mRNA metabolism. The nuclear cap-binding complex (CBC; consisting of
CBP20 and CBP80) mediates the stimulatory functions of the cap in pre-mRNA splicing, 3* end formation, and
U snRNA export. As little is known about how nuclear CBC mediates the effects of the cap in higher eukaryotes,
we have characterized proteins that interact with CBC in HeLa cell nuclear extracts as potential mediators of
its function. Using cross-linking and coimmunoprecipitation, we show that eukaryotic translation initiation
factor 4G (eIF4G), in addition to its function in the cytoplasm, is a nuclear CBC-interacting protein. We
demonstrate that eIF4G interacts with CBC in vitro and that, in addition to its cytoplasmic localization, there
is a significant nuclear pool of eIF4G in mammalian cells in vivo. Immunoprecipitation experiments suggest
that, in contrast to the cytoplasmic pool, much of the nuclear eIF4G is not associated with eIF4E (translation
cap binding protein of eIF4F) but is associated with CBC. While eIF4G stably associates with spliceosomes in
vitro and shows close association with spliceosomal snRNPs and splicing factors in vivo, depletion studies show
that it does not participate directly in the splicing reaction. Taken together the data indicate that nuclear
eIF4G may be recruited to pre-mRNAs via its interaction with CBC and accompanies the mRNA to the
cytoplasm, facilitating the switching of CBC for eIF4F. This may provide a mechanism to couple nuclear and
cytoplasmic functions of the mRNA cap structure.
RNAs transcribed by RNA polymerase II (pol II) are char-
acterized by an inverted m7G(59)ppp(59)N cap. The capping of
the pre-mRNA occurs cotranscriptionally (50, 52) and is
achieved by recruitment of the capping enzyme to the phos-
phorylated C-terminal domain of the largest subunit of pol II
(5, 22, 36). The cap contributes to many aspects of pol II
transcript metabolism, including protection against 59–39 exo-
nucleases, facilitating efficient pre-mRNA splicing, 39 end for-
mation, U snRNA and mRNA nuclear export, and translation
of mRNAs (32, 34).
Two distinct families of cap binding proteins (CBPs) medi-
ate the stimulatory effects of the cap structure. In the nucleus,
the cap structure interacts with the nuclear cap-binding com-
plex (CBC), a heterodimer consisting of two highly conserved
polypeptides, CBP80 and CBP20 (20, 23, 54). CBC plays a
direct role in pre-mRNA splicing, 39 end formation, and U
snRNA export (reviewed in reference 32). In pre-mRNA splic-
ing CBC promotes the association of U1 snRNP with the
cap-proximal 59 splice site (31, 33). In Saccharomyces cerevi-
siae, CBC interacts directly with yeast-specific components of
the U1 snRNP (13, 15). This contrasts with the mammalian
system, where there is no evidence of a direct interaction
between CBC and U1 snRNP (33). Although CBC is required
for efficient 39 end cleavage of pre-mRNA, it is not required
for polyadenylation per se (11). The cap also contributes to
mRNA export, presumably through its interaction with CBC
(25, 54) and with CBC-dependent export of U snRNAs from
the nucleus to the cytoplasm mediated by nuclear export re-
ceptor CRM1 and by PHAX (12, 43).
The effect of the cap structure on mRNA translation is
mediated by a trimeric complex termed eukaryotic translation
initiation factor 4F (eIF4F; comprising eIF4E, the helicase
eIF4A, and eIF4G), which recruits mRNA to the ribosome
(19, 38). eIF4E interacts specifically with the mRNA cap struc-
ture and is essential for cap-dependent translation (19).
eIF4G, which exists in two isoforms, plays an essential role in
the mechanism of translation by acting as a molecular bridge
between other components of the ribosomal initiation complex
(reviewed in references 19, 21, 38, 39, and 48). Within the
sequence of eukaryotic eIF4G there are domains that interact
with eIF4E, eIF4A, eIF3, the poly(A) binding protein (PABP),
and the eIF4E kinase, Mnk1 (reviewed in references 19, 21, 39,
and 48). It has been suggested that interaction between PABP
and eIF4G facilitates the functional association of the 39 end of
an mRNA with the 59 end to promote mRNA translation (21),
while the association between eIF4G and eIF4E markedly
enhances the binding of the latter to the mRNA cap (19).
During the course of our studies reported here, Fortes et al.
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(14) used a combination of biochemical and genetic ap-
proaches to demonstrate that a defined region of S. cerevisiae
eIF4G also has the ability to interact with CBP80. Further-
more, this interaction was antagonized by eIF4E, suggesting
that the exchange of nuclear for cytoplasmic CBPs may be
mediated by eIF4G (14).
To gain more insight into the role of nuclear proteins that
mediate the effects of CBC in pre-mRNA splicing and 39 end
formation, we have investigated nuclear proteins that specifi-
cally interact with capped RNA in a CBC-dependent manner.
Using immunofluorescence and biochemical analysis, we dem-
onstrate that, as with eIF4E (9), there is a nuclear pool of
eIF4G. Nuclear eIF4G exhibits partial colocalization with spli-
ceosomal snRNPs and stably associates with CBC, pre-mRNA,
and the spliceosome. These data, together with genetic studies
with S. cerevisiae CBP80 (14), further strengthen the possibility
that eIF4G has a role in coupling RNA-processing events in
the nucleus with mRNA translation in the cytoplasm.
MATERIALS AND METHODS
Chemicals and biochemicals. Materials for tissue culture were from Gibco
Life Technologies (Paisley, United Kingdom), T7 RNA polymerase was from
New England Biolabs (Hitchin, United Kingdom), [a-32P]GTP and protein A-
Sepharose were from Amersham Pharmacia Biotech (Little Chalfont, United
Kingdom), 4-thio-UTP was from United States Biochemicals, cap analogue was
from Kedar (Warsaw, Poland), and cytofectine was from Bio-Rad (Hemel
Hempstead, United Kingdom). Unless otherwise stated, all other chemicals were
from Sigma (Gillingham, United Kingdom).
4-Thio-U-substituted capped RNA and UV cross-linking. 4-Thio-U capped
RNA was synthesized basically as described by Milligan et al. (37). The oligo-
nucleotides used were T7P (TAATACGACTCACTATA) and UVXL (ATTAT
GCTGAGTGATATCCCAGACACATCTCCCCGCGCTTCC). For UV cross-
linking, reaction mixtures (20 ml) comprised 5 ml of HeLa nuclear extract, 10 mg
of Escherichia coli tRNA, 150 mM NaCl, and 4 3 104 cpm of a-32P-labeled
capped RNA and cap analogue as indicated in the figure legend. Reaction
mixtures were irradiated on ice-water for 10 min, approximately 4 cm from a
360-nm light source (BLAK-RAY long-wave UV lamp, model B100AP). One
hundred nanograms of RNase A was added for a further 10 min; samples were
then denatured, and the cross-linked products were resolved by Tris-Tricine
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (51),
dried, and exposed to X-ray film.
Extracts, immunoprecipitation, immunodepletion, and in vitro splicing. HeLa
cell nuclear extracts, prepared according to the method of Dignam (7), were
purchased from 4C (Mons, Belgium). Immunodepletion of nuclear extracts for
CBC using anti-CBP80 antibodies and splicing reactions were performed as
described previously (24); depletion of eIF4G was performed in parallel using
rabbit antiserum against the C-terminal domain of eIF4G (3, 16). For immuno-
precipitations, samples were diluted fivefold in IP150 buffer and incubated with
a 30-ml packed volume of antibody beads for 1 h at 4°C, with rotation. The beads
were then washed three times with 1 ml of ice-cold IP150 buffer, and the
recovered proteins were eluted with SDS-PAGE sample buffer. The proteins
were resolved by SDS-PAGE; gels were dried and subjected to autoradiography,
or proteins were transferred to a membrane (either nitrocellulose or polyvinyli-
dene difluoride) and probed with an antibody specific for CBP80 (24) or affinity-
purified anti-eIF4GI antibody (3).
For cell fractionation studies, HeLa cells were grown in suspension to a density
of 5 3 105 cells/ml and separated into nuclear and cytoplasmic fractions, as
described previously (35). For Western blotting, equal cell equivalents of the
nucleoplasmic and cytoplasmic fractions were resolved by SDS-PAGE and pro-
teins were visualized with serum specific for eIF4G(Ct), CBP80, g-tubulin or BiP
(Santa Cruz Biotechnology), and ECL. For quantification of the distribution of
the proteins between the nuclear and cytoplasmic compartments, a secondary
Cy5-labeled antibody was used with a Storm 860 PhosphorImager (Molecular
Dynamics) in red fluorescence mode; signals were analyzed using ImageQuant
software.
Mammalian cell culture, confocal microscopy, and subcellular fractionation.
HeLa cells were cultured as monolayers in RPMI medium supplemented with
10% fetal calf serum (FCS), and diploid human fibroblasts (WI-38; American
Type Culture Collection) were cultured in minimum essential Eagle’s medium
supplemented with nonessential amino acids and 10% FCS. For immunofluo-
rescence analysis cells were grown on glass coverslips for a minimum of 24 h and
collected when 70 to 90% confluent. Cells were briefly rinsed in phosphate-
buffered saline (PBS) and immediately fixed in 2% formaldehyde in PBS for 10
min at room temperature; all formaldehyde solutions were freshly prepared from
a 40% stock solution of paraformaldehyde in water (Electron Microscopy Sci-
ences, Fort Washington, Wash.). After fixation cells were rinsed in PBS and
subsequently permeabilized in 0.1% saponin (Sigma)–0.1% NP-40 (Fluka) in
PBS at room temperature for an additional 6 to 7 min. In some experiments cells
were simultaneously fixed and extracted in a solution containing 3.7% formal-
dehyde in HPEM buffer {30 mM HEPES, 65 mM PIPES [piperazine-N,N9-bis(2-
ethanesulfonic acid), pH 6.9], 10 mM EGTA, 2 mM MgCl2} and 0.5% Triton
X-100 for 10 min at room temperature as previously described (10); alternatively,
cells were fixed and permeabilized in 220°C acetone for 2 min (41).
eIF4GI was labeled with affinity-purified antipeptide antibody eIF4GI(Nt) or
eIF4GI(Ct) (3). Splicing snRNPs were labeled with anti-Sm monoclonal anti-
body Y12 (45), splicing factor SC-35 was detected with an anti-SC-35 monoclonal
antibody (18), and other proteins of the SR family were labeled with monoclonal
antibodies 104 and 16H3 (41, 42). Anti-mouse immunoglobulin G (IgG), anti-
mouse IgM, and antirabbit secondary antibodies coupled to either fluorescein
isothiocyanate, Texas red, or Alexa 488 were purchased from Jackson Immu-
noresearch Laboratories and were used at final dilutions ranging from 1/75 to
1/150. Leptomycin B (LMB) was used at a final concentration of 10 mg/ml for the
times indicated in the figure legends. NIH 3T3 cells were transfected with vectors
encoding FLAG-eIF4GI or myc-MNK using cytofectine according to the man-
ufacturer’s instructions. Recombinant proteins were detected with anti-FLAG-
biotin conjugate and anti-biotin-Cy3 (Sigma) and anti-myc-cy3 (Sigma). The
samples were examined using a Leica confocal microscope with three lasers
giving excitation lines at 380, 488, and 543 nm. The data from the channels were
collected separately using narrow-band-pass filter settings; in multiple staining
experiments, the laser intensities and data collection settings were adjusted to
avoid overlap (bleedthrough) between channels. Data were collected with four-
to eightfold averaging at a resolution of 512 by 512 pixels using pinhole settings
between 1.05 and 1.10 airy units. The coupled microscope was a Leica DMIBRE
equipped with a 633 water immersion objective lens (numerical aperture, 1.4).
Data sets were processed using the Leica TCS NT, version 1.4.338, software
package and were subsequently exported for preparation for printing using
Adobe Photoshop, version 5.5, and Deneba Canvas, version 7.02.
RESULTS
Characterization of CBC-dependent cross-links. To identify
novel CBC-interacting polypeptides that may mediate its func-
tion, we used a sensitive UV cross-linking strategy employing
photoactivatable nucleotide 4-thio-U (53), incorporated close
to the m7GpppG cap of a 32P-labeled synthetic RNA (m7GsU).
m7GsU was incubated with HeLa nuclear extracts and UV-
irradiated and cross-linked polypeptides were resolved by
SDS-PAGE. Figure 1A (lane 1) shows that several cross-linked
proteins, ranging from .20 to approximately 200 kDa, can be
resolved. To determine which of these proteins interact with
m7GsU in a cap-dependent manner, m7GpppG (lane 2) or
ApppG (lane 3) was added prior to UV irradiation. While the
cap analogue abolishes the cross-linking of several proteins
(especially the 100-, 110-, 130-, 160-, and 200-kDa proteins),
ApppG had little effect, demonstrating that these interactions
were cap specific. No cross-links corresponding to CBP80 or
CBP20 were observed using this technique. The most likely
explanation is that, in m7GsU mRNA, the body of the mRNA
is labeled (the first 4-thio-U being four nucleotides from the
cap) and that CBP20 and CBP80 are not amenable to efficient
cross-linking. Previous studies using cap (radioactively)-la-
beled mRNA gave a strong cross-linking of CBP20 (24, 49). To
determine whether any of the observed cap-dependent inter-
actions were also CBC dependent, the cross-linking profiles of
CBC-depleted and mock-depleted extracts were compared.
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Compared to the control extract, depletion of CBC caused a
strong reduction in cross-linking efficiency of the 100-, 130-,
160-, and 200-kDa proteins (Fig. 1B, lane 2 versus lane 1); in
contrast, the 110-kDa cross-link was not affected by depletion
of CBC. Interaction of these proteins with the mRNA cap
could be restored by addition of increasing amounts of recom-
binant, purified CBC to the depleted extract (lanes 3 to 6).
Recombinant CBC alone did not give rise to any cross-linked
proteins with molecular weights comparable to those observed
(data not shown). At the largest amount of added CBC, the
recovery of CBC-interacting proteins (CIPs) was virtually in-
distinguishable from that observed in the nondepleted extract
(lane 6 versus lane 1). Furthermore, addition of the largest
amount of CBC to a mock-depleted extract did not increase
the efficiency of cross-linking of CIPs (lane 7 versus lane 1).
These data strongly suggest that these polypeptides bind
capped RNA in a CBC-dependent manner, and we refer to
these proteins as CIP followed by the relative molecular mass
in kilodaltons (e.g., CIP200).
Identification of CIP200 as eIF4G. eIF4G plays an essential
role in the mechanism of translation in the cytoplasm by acting
as a molecular bridge between mRNA, eIF4E, and compo-
nents of the ribosomal initiation complex (reviewed in refer-
ences 19, 21, 38, 39, and 48). The size of CIP200 was consistent
with that of eIF4G; indeed, eIF4G could be specifically de-
tected in our cell fractions by Western blotting (see Fig. 3B). In
order to investigate whether CIP200 was in fact eIF4G, cross-
linking reaction mixtures (Fig. 1) were subjected to immuno-
precipitation using antibodies specific to eIF4G. Figure 2A
shows that anti-eIF4GI serum specifically precipitated proteins
that comigrated with CIP200 and to a lesser extent CIP130
(lane 5). In contrast, anti-CBP80 serum efficiently precipitated
all CIPs with the exception of CIP160 (lane 2 versus lane 1),
and none of these proteins were recovered with preimmune
serum (lane 3). Little or no coprecipitation of eIF4G from the
nuclear fraction was observed using anti-eIF4E antiserum
(lane 4), although this serum was able to recover eIF4G from
cytoplasmic extracts (16, 40) (data not shown). Furthermore,
eIF4E was precipitated from both nuclear and cytoplasmic
fractions with anti-eIF4E serum (Fig. 2B, lanes 1 and 2); the
background smear is due to the light chains from the IgGs that
comigrate. These data suggest that, although present in the
nuclear fraction (9), eIF4E is either not associated with eIF4G
or does not interact with the cap structure to an appreciable
level in our nuclear extracts. Furthermore, depletion of eIF4E
or digestion of the cross-linked products with RNase A prior to
immunoprecipitation did not significantly affect recovery of
CIP200, but the latter treatment reduced the amount of
CIP130 precipitated (data not shown).
To determine whether we could observe an interaction be-
tween nuclear CBC and eIF4G in the absence of cross-linking,
immobilized antibodies to CBP80 or preimmune serum were
incubated with HeLa nuclear extracts. Following extensive
washing of the isolated resin, proteins that coprecipitated with
CBC were resolved by SDS-PAGE and analyzed by Western
blotting. Figure 2C shows that eIF4G was recovered with anti-
CBP80 serum (lane 3) and not with preimmune serum (lane 2).
Treatment of the isolated resin with RNase A prior to washing
did not reduce the recovery of eIF4G (lane 4 versus lane 3),
suggesting a close interaction between CBP80 and eIF4G in
FIG. 1. Identification of cap-dependent cross-links and CIPs in
HeLa nuclear extracts. (A) HeLa nuclear extracts were incubated in
the absence (lane 1) or presence of 50 mM m7GpppG (lane 2) or
ApppG (lane 3) prior to UV cross-linking. Following UV cross-linking,
labeled proteins were resolved by SDS-PAGE. Left, cap-dependent
cross-links; right, molecular weight markers. (B) HeLa nuclear extracts
were either depleted of CBC (D; lanes 2 to 6) or mock-depleted (M;
lanes 1 and 7), as described in Materials and Methods. Increasing
amounts of purified, recombinant CBC were added to the depleted
extract (60, 125, 250, and 500 ng; lanes 3 to 6, respectively) before the
addition of m7GsU and UV cross-linking. CBC (500 ng) was also
added to a mock-depleted extract as a control (lane 7). Labeled pro-
teins were resolved by SDS-PAGE and visualized by autoradiography.
Left, cap-dependent cross-links; right, molecular weight markers.
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the nuclear extracts. The reciprocal experiment demonstrated
that CBP80 could be coprecipitated with anti-eIF4G antibody
(Fig. 2C, lane 7) and not with preimmune serum (lane 6) from
nuclear extracts. Again, this interaction was unaffected by
RNase treatment of the resin prior to washing (data not
shown).
eIF4GI is distributed between the cytoplasm and nucleus.
Although the role of eIF4G in the initiation of protein synthe-
sis has been extensively investigated, little is known about its
subcellular localization. To further investigate the localization
of eIF4GI, we used indirect immunofluorescence followed by
analysis using confocal microscopy. HeLa cells, human diploid
fibroblasts, and mouse NIH 3T3 cells were fixed and perme-
abilized according to three distinct protocols and labeled with
two independent affinity-purified antibodies directed against
eIF4GI. As expected, both antibodies displayed widespread
intense cytoplasmic staining in the majority of the cells during
interphase (Fig. 3A, left, and data not shown). In addition to
this cytoplasmic labeling, an easily identifiable nuclear staining
was observed in the HeLa cells, nontransformed human fibro-
blasts, and NIH 3T3 cells. This comprised numerous bright foci
of higher concentrations of eIF4GI superimposed on a more-
diffuse nucleoplasmic labeling; nucleolar staining could not be
detected to any significant extent. We note that a similar stain-
ing pattern was observed irrespective of the fixation and per-
meabilization protocol used (data not shown). In addition, we
have consistently observed that in a minor, but still significant,
proportion of cells in a population the nucleoplasmic labeling
was more prominent than its cytoplasmic counterpart (Fig. 3A,
eIF4GI and DAPI panels). The specificity of the antibody used
for the immunostainings shown was assayed on a Western blot
of nuclear and cytoplasmic extracts and recognized predomi-
nantly a single band corresponding to eIF4GI in both extracts
(Fig. 3B); the lower species probably correspond to degrada-
tion products. In addition, we transfected NIH 3T3 cells with a
FLAG-tagged eIF4GI construct and determined the localiza-
FIG. 2. eIF4G (CIP200) interacts with nuclear CBC. (A) HeLa nuclear extracts were incubated with m7GsU and subjected to UV cross-linking.
Cross-linked proteins were immunoprecipitated (immuno-ppt) using immobilized antibodies to CBP80 (lane 2), eIF4E (lane 4), or eIF4G (lane
5) or those derived from a preimmune (PI) bleed (lane 3). Lane 1, input to the immunoprecipitation. (B) HeLa nuclear (N) or cytoplasmic extracts
(C) were subjected to immunoprecipitation in the absence (lanes 3 and 4) or presence (lanes 1 and 2) of antiserum specific for eIF4E. The proteins
recovered in immunocomplexes were resolved by SDS-PAGE, and recovery of eIF4E was visualized by Western blotting using an alkaline
phosphatase-conjugated secondary antibody. (C) HeLa nuclear extract was subjected to immunoprecipitation using either preimmune antiserum
(lane 2) or an anti-CBP80 antibody (lanes 3 and 4), as described in Materials and Methods. Lane 1, input to the immunoprecipitation. Prior to
being washed, the recovered resin was incubated for 10 min in the absence (lane 3) or presence (lane 4) of 50 mg of RNase A/ml and then processed
as described in Materials and Methods. The proteins were recovered from immunocomplexes using nondenaturing conditions and then denatured
and resolved by SDS-PAGE, and eIF4GI was visualized using anti-eIF4GI(Ct) and Western blotting using ECL. In the reciprocal experiment
immunoprecipitations were performed using either preimmune antiserum (lane 6) or an anti-eIF4GI antibody (lane 7), as described above. Lane
5, input to the immunoprecipitation. The proteins were recovered as described in Materials and Methods and probed using anti-CBP80 antiserum.
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tion of expressed eIF4GI using an anti-FLAG antibody. The
staining pattern of expressed eIF4G was similar to that ob-
served for the endogenous protein, with little staining using the
anti-FLAG antiserum in the absence of eIF4G expression (Fig.
3A, right, and data not shown).
To examine more directly the subcellular distribution of
eIF4GI, exponentially growing HeLa cells were separated into
nuclear and cytoplasmic fractions. Cell equivalents of both
fractions were resolved by SDS-PAGE, and the distribution of
eIF4GI, BiP, g-tubulin, and CBP80 was determined by immu-
noblotting and enhanced chemiluminescence (ECL) detection
(Fig. 3C) or, alternatively, the distribution was quantified using
Cy5-labeled secondary antibodies and fluorescence. In agree-
ment with the immunolocalization data presented in Fig. 3A,
eIF4GI was predominantly cytoplasmic (Fig. 3C). Quantifica-
tion of these data showed that approximately 22% of the
eIF4GI was nuclear at steady state. Consistent with the ability
of CBC to shuttle between the nucleus and cytoplasm, CBP80
was present in both the cytoplasmic and nuclear fractions, with
approximately 74% being in the nuclear fraction. The finding
that g-tubulin and BiP show only minor contamination in the
nuclear fraction (approximately 11 and 7%, respectively) indi-
cates that there is a bona fide nuclear pool of eIF4GI in
mammalian cells, a fraction of which is associated with CBC.
eIF4GI specifically associates with the spliceosome in vitro.
To determine whether eIF4GI plays a role in pre-mRNA splic-
FIG. 3. eIF4GI is distributed between the nucleus and cytoplasm. (A) HeLa cells were cultured on coverslips and fixed, endogenous eIF4G was
localized by using affinity-purified anti-eIF4GI(Ct) antiserum (left), and DNA was stained with DAPI (49,69-diamidino-2-phenylindole) (middle).
Note that eIF4GI localizes to both the nucleus and the cytoplasm and that some cells display strong nuclear staining (arrowheads). NIH 3T3 cells
were grown on coverslips (right) and transfected with a vector encoding FLAG-eIF4G. Expressed eIF4G was localized using an anti-FLAG
antibody (upper), and DNA was visualized by DAPI staining (lower). A transfected and a nontransfected (arrowhead) cell are shown side by side;
epitope-tagged eIF4GI can be detected in both the nucleus and the cytoplasm of the transfected cell. (B) HeLa cells were separated into nuclear
(N) and cytoplasmic (C) fractions, as described in Materials and Methods. The recovery of eIF4G in the nuclear and cytoplasmic fractions was
visualized by SDS-PAGE and immunoblotting using an affinity-purified antibody. (C) HeLa cells were separated into nuclear and cytoplasmic
fractions as described above. Cell equivalents of the nuclear and cytoplasmic fractions were loaded, separated by SDS-PAGE, and blotted. The
recovery of eIF4G [using antisera specific to eIF4G(Ct)], CBP80, BiP, and g-tubulin in the nuclear and cytoplasmic fractions was monitored by
SDS-PAGE and Western blotting using ECL.
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ing, we first asked whether eIF4GI associates with splicing
complexes. In vitro splicing reaction mixtures were immuno-
precipitated using antiserum specific for CBP80, eIF4G, or
preimmune serum, and the recovered radiolabeled RNA was
visualized by gel electrophoresis and autoradiography. Figure
4A shows that anti-CBP80 (lane 2) coprecipitated the pre-
mRNA, the mature RNA products, and the exon lariat and 59
exon (33). Anti-eIF4G precipitated a similar set of RNA prod-
ucts (lane 3) with decreased, but still significant, recovery of
intermediates of the splicing reaction, indicating the associa-
tion of eIF4G with the splicing complexes. This interaction is
specific, as eIF4G preimmune serum showed very low recovery
of RNA (lane 4 versus lane 3). These data suggest that eIF4GI
stably associates with the spliceosome and might participate
directly in the splicing reaction. To test this more directly,
splicing extracts were immunodepleted of CBC using anti-
CBP80 (33) or of eIF4G using immobilized antisera. As shown
in Fig. 4B, depletion of both proteins was extensive but incom-
plete; repeated attempts to further deplete these extracts were
not successful, indicating a population of these proteins which
were refractory to this process (data not shown). When assayed
in a splicing reaction with Ad1 pre-mRNA, depletion of CBC
resulted in a severe reduction in capped-mRNA splicing effi-
ciency (Fig. 4C, lane 3 versus lane 1), with a lesser effect on
cap-independent splicing (lane 4 versus lane 2), in agreement
with published data (33). However, immunodepletion of
eIF4GI to levels similar to those observed for CBP80 from
nuclear extracts had no effect on the efficiency of capped (lane
7 versus 5) or cap-independent pre-mRNA (lanes 8 versus lane
6) splicing in vitro. Similar results were observed for mock-
depleted and eIF4GI-depleted extracts when assayed with a
number of pre-mRNA templates (data not shown). Although
this makes it unlikely that eIF4GI mediates the effects of CBC
in facilitating the association of U1 snRNP with the cap-prox-
imal 59 splice site, we cannot exclude the possibility that it may
be required for splicing specific transcripts (see below).
eIF4G colocalizes with spliceosomal snRNPs in cultured
cells. Given the association of eIF4GI with CBC and spliceo-
somes, we were particularly interested in understanding the
relationship between the intranuclear distribution of eIF4GI
and that of components of the splicing machinery. To achieve
this, we performed double-labeling experiments where
eIF4GI-specific affinity-purified antiserum was used in combi-
nation with monoclonal antibodies directed against compo-
nents of the splicing apparatus (Fig. 5A and D). As previously
described, the anti-SC-35 monoclonal antibody revealed a
prominent speckled nucleoplasmic pattern (B) (18). When the
confocal images of the SC-35 and eIF4GI staining were super-
imposed, it was apparent that, although the two patterns were
dissimilar, there was a close spatial relationship between sites
of more intense eIF4GI staining and nuclear speckles (Fig.
5C). Indeed, a large proportion of the eIF4GI foci localized to,
and partially overlapped with, the periphery of SC-35 speckles
(C, inset). In agreement with earlier studies (4, 45), the Y12
monoclonal antibody, which recognizes an epitope common to
all splicing snRNPs, also elicits a speckled pattern on a diffuse
nucleoplasmic staining, with a small number of very bright foci
being discerned (E). In merged images of the Y12 and eIF4GI
staining patterns a significant proportion of the eIF4GI foci
localized to snRNP-enriched regions, which again mostly cor-
responded to the periphery of nuclear speckles (F). However,
although concentration of eIF4GI within a speckle was a rare
event, partial overlap between eIF4GI and snRNP labeling at
the borders of these structures was frequently observed. The
FIG. 4. eIF4G associates with splicing complexes in vitro. (A) 32P-labeled m7G-capped Ad1 pre-mRNA was spliced in HeLa nuclear extract
using standard conditions for 90 min. Immunoprecipitations were performed using an anti-CBP80 antibody (lane 2), an eIF4G antibody (lane 3),
or preimmune (P.I.) serum (lane 4). RNA was recovered from the immune complex and resolved on a denaturing urea-polyacrylamide gel; lane
1, input to the immunoprecipitation. (B) HeLa nuclear splicing extracts were depleted with an immobilized antibody specific to either CBP80
(upper) or eIF4G (lower). The extent of depletion was monitored by Western blotting using specific antibodies against CBP80 (upper) or eIF4G
(lower). (C) CBP80-depleted and eIF4G-depleted extracts, with their respective mock-depleted controls, were assayed for their ability to splice
either m7G-capped (odd lanes) or A-capped Ad1 pre-mRNA (even lanes). The RNA was recovered from the splicing reaction and resolved on
a denaturing urea-polyacrylamide gel, as described for panel A.
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FIG. 5. eIF4G partially colocalizes with spliceosomal snRNPs in vivo. HeLa cells were grown on coverslips and double labeled with an
affinity-purified anti-eIF4G(Ct) antibody (A and D) and a monoclonal antibody specific for the SC-35 splicing factor (B). In the merge of the two
channels (C and inset) note the close spatial relationship between eIF4G-rich sites (red signal) and the nuclear speckles (green signal). Double
labelings with anti-eIF4GI (D) and the Y12 monoclonal antibody (E) show that nuclear staining of eIF4G partially colocalizes with the snRNP
distribution; this is evidenced in the merged image (F; eIF4G staining, red signal; snRNP staining, green signal), where the nuclear staining of
eIF4GI is mostly orange due to a partial overlap with the snRNP staining pattern. This is further shown in panel G (inset); the graph depicts the
intensities of the signals from eIF4GI (red line) and snRNP (green line) staining across the dotted line (inset). Note that there is a substantial
codistribution of the eIF4G and snRNP labeling, with specific foci observed at the edges of nuclear speckles.
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nuclear eIF4GI staining is orange compared to the cytoplasmic
red staining, indicating colocalization with the diffuse Y12
staining. This was further demonstrated using a quantitative
line scan through an optical section of the nucleus and repre-
senting the data graphically (Fig. 5G). The line that was quan-
tified is shown above the graph. Several peaks of eIF4G and
Y12 fluorescence colocalize; however, in contrast, many of the
foci are spatially very close, and overlap at the periphery of
peaks is observed. This colocalization of eIF4G staining with a
subset of snRNP foci is consistent with the possibility that
eIF4G may be required only for the processing of a subset of
pre-mRNAs.
Cellular distribution of eIF4GI is insensitive to LMB.
Within the sequence of eIF4GI there are a number of putative
nuclear localization signals and also putative leucine-rich nu-
clear export signals, indicative of a protein that shuttles via the
CRM1/exportin 1 pathway. To examine whether eIF4G,
eIF4E, and the eIF4E kinase, Mnk1, actively shuttle between
the nucleus and the cytoplasm using this pathway, we treated
cells with LMB, an inhibitor of CRM1-/exportin 1-mediated
nuclear export (28, 55). NIH 3T3 cells were transfected with
vectors containing either FLAG-tagged eIF4GI (46) or a myc-
tagged version of Mnk1 (56). After 48 h, cells were treated with
LMB for 3 h and the endogenous eIF4E and eIF4GI or trans-
fected FLAG-eIF4GI or myc-Mnk1 was localized using the
appropriate antibody (Fig. 6). While both endogenous eIF4GI
protein and transfected FLAG-eIF4GI were predominantly
cytoplasmic, they also exhibited detectable levels of nuclear
staining. However, the distribution of eIF4GI was not signifi-
cantly altered by treatment of cells with LMB (Fig. 6). A
similar result was obtained with endogenous eIF4E. In con-
trast, LMB treatment of cells caused a clear accumulation of
myc-Mnk1 in the nucleus, consistent with its reported genetic
interaction with importin-a (55). These data suggest that, while
Mnk1 is exported from the nucleus using the CRM1-/exportin
1-dependent export pathway, eIF4GI and eIF4E must shuttle
using a different export mechanism.
DISCUSSION
Using UV cross-linking assays and coprecipitation studies,
we have shown that there are several CIPs in HeLa nuclear
extracts (Fig. 1). Although the identity and function of many of
these proteins remain to be determined (e.g., CIP160, CIP130,
and CIP100), we have identified CIP200 as eIF4GI (Fig. 2).
Cellular fractionation and indirect immunofluorescence have
shown that significant amounts of eIF4GI are present in the
nucleus in addition to the expected cytoplasmic localization
(Fig. 3 and 5). In the cytoplasm, eIF4G plays an essential role
in translation by acting as an adapter molecule during the
initiation phase of protein synthesis. Within its sequence, it
contains domains that interact with eIF4E, eIF4A, eIF3,
PABP, and Mnk1 (reviewed in references 19, 21, 39, and 48).
More recently, S. cerevisiae eIF4G has also been shown to
interact with the large subunit of CBC, CBP80, via a domain
between those interacting with eIF4E and eIF3 (14). Our data
suggest that, in contrast to the cytoplasmic eIF4F complex
(39), nuclear eIF4G in mammalian cells may not interact with
eIF4E, but rather is closely associated with CBC and CIP130
(Fig. 2). At this time it is not known which region(s) of mam-
malian eIF4GI plays a role in its interaction with CBC, as
sequence analysis failed to reveal any strong homology be-
tween the identified domain of S. cerevisiae eIF4G (14) and
human eIF4G. However, these data suggest that the interac-
tion between CBP80 and eIF4G may be evolutionarily con-
served. Unfortunately, we have been unable to perform colo-
calization studies with CBP80 and eIF4G as the primary
antibodies were raised in the same species. Although the as-
sociation of CBC with eIF4G was insensitive to RNase treat-
ment, suggesting that this interaction did not require RNA,
these data do not discount the possibility that the eIF4G in-
teraction with CBC is indirect and mediated by other nuclear
proteins.
We show that, in addition to its interaction with the nuclear
CBC, eIF4GI is stably associated with capped RNA through-
out pre-mRNA splicing in vitro (Fig. 4). Consistent with this,
we find a significant, but incomplete overlap between eIF4G
and Y12 nuclear staining in vivo (Fig. 5). While the putative
role of eIF4G in splicing is unclear, our data support a model
whereby eIF4GI from the nuclear pool may be recruited to
nascent pre-mRNA transcripts via its interaction with CBC
and possibly also RNA (27), and this may be important for
downstream events in gene expression. During the course of
our work, it was reported that S. cerevisiae eIF4G can interact
with CBP80 via a domain between those recruiting eIF4E and
eIF3 (14). Furthermore, evidence from yeast two-hybrid stud-
ies have demonstrated that Prp11p, a component of yeast U2
snRNP, interacts with eIF4G (17), and we have shown that this
FIG. 6. Nuclear localization of endogenous eIF4G and eIF4E is
insensitive to LMB. NIH 3T3 cells grown on coverslips were either
nontransfected or transfected with vectors encoding Myc-Mnk1 or
FLAG-eIF4GI, as indicated. After 48 h cells were treated with either
LMB (right) or control buffer (left) for 3 h before being fixed and
stained, as indicated. In nontransfected cells, endogenous eIF4GI and
eIF4E were detected using affinity-purified antibodies and the trans-
fected proteins were visualized using commercial antibodies.
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interaction is direct (Y. Kafasla and J. D. Lewis, unpublished
observations). Together, these data suggest that eIF4G may
play a role in nuclear pre-mRNA processing prior to export
and translation. Although immunodepletion of eIF4GI from
nuclear extracts had little effect on the Ad1 pre-mRNA splic-
ing efficiency in vitro (Fig. 4), we cannot rule out the possibility
that the residual levels of eIF4GI supported efficient splicing
or that not all pre-mRNAs require eIF4GI for this process.
The latter would also be consistent with our data (Fig. 5),
indicating that eIF4G partially colocalized with a proportion of
snRNPs at discrete foci. An alternative explanation is that
eIF4GII may substitute for eIF4GI in these assays. In support
of this, preliminary studies have shown that eIF4GII has a
cellular distribution similar to that of eIF4GI (data not shown).
However, due to limiting amounts of suitable reagents, we
have been unable to address biochemically whether eIF4GII
interacts with CBP80 or functions in splicing.
At this time, it is not known how eIF4G is localized to the
nuclear pool. Our results with LMB (Fig. 6) indicate that, in
contrast to Mnk1, the CRM1/exportin 1-dependent pathway is
not involved in the export of eIF4GI or eIF4E from the nu-
cleus. As generic mRNA export is not sensitive to inhibition by
LMB in mammalian cells (12, 44, 55), these data are consistent
with a model whereby the eIF4G-CBC-mRNA complex is part
of the export substrate. Dostie et al. (8) have recently charac-
terized a nuclear import adapter for eIF4E and shown that
LMB causes transfected eIF4E and the 4E transporter to ac-
cumulate in the nucleus. As the localization of endogenous
eIF4E and eIF4G was insensitive to LMB treatment of cells
(Fig. 6), it is not known how these proteins are recycled to the
cytoplasm or whether they represent a novel, separate pool of
initiation factors. Future efforts will be directed at determining
the site of interaction of CBC with mammalian eIF4G, which
cis-acting signals are responsible for the import of eIF4GI into
the nucleus, and also which transporters are involved in its
export.
Recently MIF4G, a domain that is conserved between
eIF4G, NMD2/Upf2, and CBP80, has been described, impli-
cating CBP80 and eIF4G in nonsense-mediated decay (47).
One attractive model is that CBC bound to the cap of an
mRNA interacts with eIF4G at the 59 end, which interacts with
PABP (a shuttling protein [1]) bound to the poly(A) tail at the
39 end. This would circularize mRNA in the nucleus in a
manner analogous to that described for mRNA in the cyto-
plasm (57). Studies on Balbiani ring mRNA in Chironomous
tentans have shown that the nuclear CBC binds early to the
nascent transcript and then accompanies the mRNP during
nuclear export (54). This large mRNP has a highly structured
crescent morphology that would juxtapose the 59 and 39 ends,
indicating that the cap and poly(A) tail may well be in close
physical contact in the nucleus. As such, the interaction of
eIF4G with CBC would play a central role in allowing the cell
to ensure that mRNAs are properly capped and polyadenyl-
ated prior to nuclear export, with defective RNAs being de-
graded in the nucleus; indeed recent work has implicated
CBP80 in nuclear-RNA degradation (6). Work from a number
of laboratories has shown that exon-exon junctions of spliced
mRNAs are marked by nuclear proteins and that these may be
implicated in coupling nuclear RNA splicing with export and
recognition of premature stop codons (26, 29, 30, 58). Further
work is needed to determine the exact role of CBP80 and
eIF4G in nonsense-mediated mRNA decay and nuclear
mRNA degradation
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